Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

Presentation TCT 2016

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

Presenter: Sorin J. Brener, Jean-François Tanguay, Michela Faggioni

October 31, 2016

Presentation TCT 2012

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

Advertisement

What’s Going to Be Hot at TCT 2025

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Long-term Absorb BVS Data Continue to Disappoint

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content